Indaptus Therapeutics (INDP) Short Interest Ratio & Short Volume $7.30 -0.86 (-10.54%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$7.40 +0.09 (+1.30%) As of 08/1/2025 06:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Indaptus Therapeutics Short Interest DataIndaptus Therapeutics (INDP) has a short interest of 14,700 shares, representing 3.10% of the float (the number of shares available for trading by the public). This marks a -50.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 24,014 shares to cover all short positions.Current Short Interest14,700 sharesPrevious Short Interest29,900 sharesChange Vs. Previous Month-50.84%Dollar Volume Sold Short$179.19 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares570,000 sharesFloat Size474,000 sharesShort Percent of Float3.10%Today's Trading Volume9,424 sharesAverage Trading Volume24,014 sharesToday's Volume Vs. Average39% Short Selling Indaptus Therapeutics? Sign up to receive the latest short interest report for Indaptus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINDP Short Interest Over TimeINDP Days to Cover Over TimeINDP Percentage of Float Shorted Over Time Indaptus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202514,700 shares $179.19 thousand -50.8%3.1%0.1 $12.19 6/30/202529,900 shares $314.85 thousand -96.0%5.2%0.1 $10.53 6/15/2025748,000 shares $242.95 thousand -26.7%5.8%0.1 $0.32 5/31/20251,020,000 shares $343.33 thousand +1,157.7%7.9%1.5 $0.34 5/15/202581,100 shares $34.06 thousand -32.4%0.6%0.2 $0.42 4/30/2025119,900 shares $55.15 thousand -8.5%0.9%0.3 $0.46 4/15/2025131,100 shares $66.11 thousand -40.7%1.0%0.3 $0.50 3/31/2025221,200 shares $121.64 thousand +322.1%1.9%0.6 $0.55 3/15/202552,400 shares $42.19 thousand -10.0%0.5%0.1 $0.81 2/28/202558,200 shares $48.83 thousand -25.9%0.5%2.5 $0.84 Get the Latest News and Ratings for INDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Indaptus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202578,500 shares $62.72 thousand +102.8%0.7%3.1 $0.80 1/31/202538,700 shares $35.22 thousand -41.7%0.4%1.6 $0.91 1/15/202566,400 shares $57.77 thousand -11.2%0.7%0.6 $0.87 12/31/202474,800 shares $62.99 thousand -19.1%0.8%0.7 $0.84 12/15/202492,500 shares $92.50 thousand +0.5%1.0%0.8 $1.00 11/30/202492,000 shares $93.84 thousand +8.2%1.1%0.8 $1.02 11/15/202485,000 shares $94.35 thousand -38.7%1.1%0.8 $1.11 10/31/2024138,700 shares $162.28 thousand +348.9%1.9%1.3 $1.17 10/15/202430,900 shares $39.24 thousand -9.7%0.4%0.3 $1.27 9/30/202434,200 shares $42.41 thousand +284.3%0.5%2.5 $1.24 9/15/20248,900 shares $13.44 thousand +140.5%0.1%0.7 $1.51 8/31/20243,700 shares $6.10 thousand -47.9%0.1%0.3 $1.65 8/15/20247,100 shares $11.86 thousand -12.4%0.1%0.4 $1.67 7/31/20248,100 shares $16.52 thousand -42.6%0.1%0.4 $2.04 7/15/202414,100 shares $31.02 thousand +147.4%0.2%0.7 $2.20 6/30/20245,700 shares $12.08 thousand +9.6%0.1%0.2 $2.12 6/15/20245,200 shares $12.84 thousand -66.7%0.1%0.2 $2.47 5/31/202415,600 shares $36.97 thousand -6.0%0.3%0.5 $2.37 5/15/202416,600 shares $36.69 thousand -35.7%0.3%0.2 $2.21 4/30/202425,800 shares $55.99 thousand -70.1%0.4%0.3 $2.17 4/15/202486,200 shares $228.43 thousand -13.9%1.5%1 $2.65 3/31/2024100,100 shares $224.22 thousand +0.7%1.7%1.3 $2.24 3/15/202499,400 shares $185.88 thousand +196.7%1.7%1.3 $1.87 2/29/202433,500 shares $73.70 thousand +94.8%0.6%0.5 $2.20 2/15/202417,200 shares $29.93 thousand +18.6%0.3%1.8 $1.74 1/31/202414,500 shares $23.93 thousand -20.8%0.3%1.5 $1.65 1/15/202418,300 shares $33.86 thousand -10.7%0.3%1.3 $1.85 12/31/202320,500 shares $36.08 thousand -9.3%0.4%1.5 $1.76 12/15/202322,600 shares $44.75 thousand -2.6%0.4%1.7 $1.98 11/30/202323,200 shares $52.43 thousand +21.5%0.4%1.4 $2.26Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 11/15/202319,100 shares $42.02 thousand +64.7%0.3%1 $2.20 10/31/202311,600 shares $26.45 thousand -3.3%0.2%0.5 $2.28 10/15/202312,000 shares $30.72 thousand -14.3%0.2%0.6 $2.56 9/30/202314,000 shares $38.57 thousand -31.7%0.2%0.7 $2.76 9/15/202320,500 shares $69.29 thousand -9.3%0.4%1 $3.38 8/31/202322,600 shares $64.86 thousand -51.6%0.4%1.3 $2.87 8/15/202346,700 shares $104.61 thousand +115.2%0.8%2.8 $2.24 7/31/202321,700 shares $44.92 thousand +29.9%0.4%1.6 $2.07 7/15/202316,700 shares $31.73 thousand -1.8%0.3%1.3 $1.90 6/30/202317,000 shares $32.47 thousand -28.3%0.3%0.6 $1.91 6/15/202323,700 shares $46.45 thousand -11.9%0.4%0.8 $1.96 5/31/202326,900 shares $43.85 thousand -0.4%0.5%0.9 $1.63 5/15/202327,000 shares $56.16 thousand -51.4%0.5%1 $2.08 4/30/202355,600 shares $145.06 thousand +159.8%1.0%2 $2.61 4/15/202321,400 shares $41.73 thousand -9.3%0.4%0.8 $1.95 3/31/202323,600 shares $43.66 thousand -12.6%0.4%3.1 $1.85 3/15/202327,000 shares $41.04 thousand +4.7%0.5%2.9 $1.52 2/28/202325,800 shares $45.15 thousand -21.3%0.5%1 $1.75 2/15/202332,800 shares $58.71 thousand -16.1%0.6%1.3 $1.79 1/31/202339,100 shares $69.21 thousand +3.7%0.7%1.5 $1.77 1/15/202337,700 shares $61.45 thousand -29.8%0.7%1.5 $1.63 12/30/202253,700 shares $77.87 thousand -46.3%1.1%2.2 $1.45 12/15/2022100,000 shares $195 thousand +498.8%2.0%4.2 $1.95 11/30/202216,700 shares $30.42 thousand -4.6%0.3%1.6 $1.82 11/15/202217,500 shares $30.28 thousand +5.4%0.4%1.6 $1.73 10/31/202216,600 shares $30.38 thousand +9.2%0.3%1.4 $1.83 10/15/202215,200 shares $27.36 thousand -14.6%0.3%1.1 $1.80 9/30/202217,800 shares $38.45 thousand -21.9%0.4%1.1 $2.16 9/15/202222,800 shares $61.10 thousand -8.1%0.5%0.9 $2.68 8/31/202224,800 shares $62.50 thousand -31.7%0.5%0.7 $2.52 8/15/202236,300 shares $105.27 thousand -36.9%0.7%0.6 $2.90 7/31/202257,500 shares $163.30 thousand -25.3%1.1%0.1 $2.84 7/15/202277,000 shares $256.41 thousand +49.8%1.5%0.2 $3.33 6/30/202251,400 shares $134.15 thousand -42.6%1.0%0.1 $2.61 6/15/202289,500 shares $200.48 thousand -50.9%1.6%0.2 $2.24 5/31/2022182,100 shares $460.71 thousand +569.5%3.2%0.4 $2.53 5/15/202227,200 shares $67.46 thousand -38.3%0.5%0.1 $2.48 4/30/202244,100 shares $129.21 thousand -14.7%0.8%1 $2.93 4/15/202251,700 shares $177.33 thousand -18.1%0.9%0.9 $3.43 3/31/202263,100 shares $252.40 thousand -30.6%1.1%0.8 $4.00 3/15/202290,900 shares $289.97 thousand +21.2%1.6%0.6 $3.19 2/28/202275,000 shares $313.50 thousand +6.8%1.4%0.4 $4.18 2/15/202270,200 shares $351 thousand -34.2%1.3%0.3 $5.00 1/31/2022106,600 shares $531.93 thousand +2.8%1.9%0.4 $4.99 1/15/2022103,700 shares $547.54 thousand +157.3%1.9%0.4 $5.28 12/31/202140,300 shares $229.71 thousand No Change0.7%0.1 $5.70 INDP Short Interest - Frequently Asked Questions What is Indaptus Therapeutics' current short interest? Short interest is the volume of Indaptus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 14,700 shares of INDP short. 3.10% of Indaptus Therapeutics' shares are currently sold short. Learn More on Indaptus Therapeutics' current short interest. What is a good short interest percentage for Indaptus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.10% of Indaptus Therapeutics' floating shares are currently sold short. Is Indaptus Therapeutics' short interest increasing or decreasing? Indaptus Therapeutics saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 14,700 shares, a decline of 50.8% from the previous total of 29,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Indaptus Therapeutics' float size? Indaptus Therapeutics currently has issued a total of 570,000 shares. Some of Indaptus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Indaptus Therapeutics currently has a public float of 474,000 shares. How does Indaptus Therapeutics' short interest compare to its competitors? 3.10% of Indaptus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Indaptus Therapeutics: Dare Bioscience, Inc. (12.74%), Aytu BioPharma Inc. (9.76%), Reviva Pharmaceuticals Holdings, Inc. (12.60%), Cadrenal Therapeutics, Inc. (1.53%), Elevation Oncology, Inc. (3.92%), VYNE Therapeutics Inc. (2.45%), Relmada Therapeutics, Inc. (1.28%), Cyclacel Pharmaceuticals, Inc. (7.79%), Moleculin Biotech, Inc. (18.97%), Passage Bio, Inc. (4.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Indaptus Therapeutics stock? Short selling INDP is an investing strategy that aims to generate trading profit from Indaptus Therapeutics as its price is falling. INDP shares are trading down $0.86 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Indaptus Therapeutics? A short squeeze for Indaptus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INDP, which in turn drives the price of the stock up even further. How often is Indaptus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INDP, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies DARE Short Interest Data AYTU Short Interest Data RVPH Short Interest Data CVKD Short Interest Data ELEV Short Interest Data VYNE Short Interest Data RLMD Short Interest Data CYCC Short Interest Data MBRX Short Interest Data PASG Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INDP) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INDP Stock Alerts